INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
International Agency For Research On Cancer
Lyon, FranciaPublicaciones en colaboración con investigadores/as de International Agency For Research On Cancer (10)
2021
-
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
Genome Medicine, Vol. 13, Núm. 1
-
Risk Factors for Childhood Leukemia: Radiation and Beyond
Frontiers in Public Health, Vol. 9
2016
2013
-
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: A case-control study in the context of the IMMEnSE consortium
Journal of Human Genetics, Vol. 58, Núm. 3, pp. 155-159
2012
-
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium
British Journal of Haematology, Vol. 157, Núm. 3, pp. 331-338
-
Genetics and molecular epidemiology of multiple myeloma: The rationale for the IMMEnSE consortium (review)
International Journal of Oncology, Vol. 40, Núm. 3, pp. 625-638
-
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma
British Journal of Haematology
2011
2010
-
International network of cancer genome projects
Nature, Vol. 464, Núm. 7291, pp. 993-998